IP Library Granted Patent US 10,240,184
Granted Patent B2
US 10,240,184 · App. 15/376,139 · Granted Mar 26, 2019

Covalent tethering of functional groups to proteins

Inventors: Keith V. Wood (Mt. Horeb, WI); Georgyi V. Los (Madison, WI); Robert F. Bulleit (Verona, WI); Dieter Klaubert (Arroyo Grande, CA); Mark McDougall (Arroyo Grande, CA); Chad Zimprich (Stoughton, WI)
Assignee: Promega Corporation
C12Q1/34C07C217/08C07C271/16C07D209/48C07D233/64C07D311/78C07D311/82C07D405/06C07D493/10C07D495/04C07F5/022C12N9/14C12N9/86C12Y308/01005G01N33/5005G01N33/58Y10S436/80
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,240,184
App. No.
15/376,139
Granted
Mar 26, 2019
Kind
B2
Abstract

A mutant hydrolase optionally fused to a protein of interest is provided. The mutant hydrolase is capable of forming a bond with a substrate for the corresponding nonmutant (wild-type) hydrolase which is more stable than the bond formed between the wild-type hydrolase and the substrate. Substrates for hydrolases comprising one or more functional groups are also provided, as well as methods of using the mutant hydrolase and the substrates of the invention. Also provided is a fusion protein capable of forming a stable bond with a substrate and cells which express the fusion protein.

Claims (20)

1. A composition comprising a dehalogenase substrate of the formula R-linker-A-X, wherein R is a fluorogenic or luminogenic molecule, A-X is a substrate for said dehalogenase, X is a halogen, and the linker is a group that separates R and A; wherein R, linker, A, and X are covalently linked.

2. The composition of claim 1 , wherein A is (CH2)n and n=4-10.

3. The composition of claim 2 , wherein A is (CH2)n and n=6-10.

4. The composition of claim 1 , wherein the linker is a branched or unbranched carbon chain comprising no more than 30 carbons.

5. The composition of claim 4 , wherein the linker comprises —C(O)NH(CH2CH2O)y, wherein y=2-8.

6. The composition of claim 1 , wherein X is Cl or Br.

7. The composition of claim 1 , wherein linker-A separates R and X by at least 11 atoms.

8. A method to label a cell, comprising:

(a) contacting a cell comprising a mutant dehalogenases with the composition of claim 1 , wherein the mutant dehalogenase comprises at least one amino acid substitution relative to the corresponding wild-type dehalogenase, wherein the at least one amino acid substitution results in the mutant dehalogenase forming a bond with the substrate which is more stable than the bond formed between the corresponding wild-type dehalogenase and the substrate, wherein the at least one amino acid substitution in the mutant dehalogenases is a substitution (i) at an amino acid residue in the corresponding wild-type dehalogenase that is associated with activating a water molecule which cleaves the bond formed between the corresponding wild-type dehalogenase and the substrate, or (ii) at an amino acid residue in the corresponding wild-type dehalogenase that forms an ester intermediate with the substrate;

(b) incubating the cell with the composition, wherein incubation results in the cell being labeled with the fluorogenic or luminogenic molecule; and

(c) detecting a change in fluorescence or luminescence upon said composition binding to said mutant dehalogenase.

9. The method of claim 8 , wherein the substrate is a substrate for a Rhodococcus dehalogenase.

10. The method of claim 8 , wherein X is Cl or Br.

11. The method of claim 8 , wherein the linker comprises —C(O)NH(CH2CH2O)y, wherein y=2-8.

12. A method to detect or determine the presence or amount of a mutant dehalogenases, comprising:

(a) contacting a mutant dehalogenase with the composition of claim 1 , wherein the mutant dehalogenase comprises at least one amino acid substitution relative to the corresponding wild-type dehalogenase, wherein the at least one amino acid substitution results in the mutant dehalogenase forming a bond with the substrate which is more stable than the bond formed between the corresponding wild-type dehalogenase and the substrate, wherein the at least one amino acid substitution in the mutant dehalogenase is a substitution (i) at an amino acid residue in the corresponding wild-type dehalogenase that is associated with activating a water molecule which cleaves the bond formed between the corresponding wild-type dehalogenase and the substrate or (ii) at an amino acid residue in the corresponding wild-type dehalogenase that forms an ester intermediate with the substrate; and

(b) detecting a change in fluorescence or luminescence upon said composition binding to said mutant dehalogenase, thereby detecting or determining the presence or amount of the mutant dehalogenase.

13. The method of claim 12 , wherein the substrate is a substrate for a Rhodococcus dehalogenase.

14. The method of claim 12 , wherein X is Cl or Br.

15. The method of claim 12 , wherein the linker comprises —C(O)NH(CH2CH2O)y, wherein y=2-8.

Assignments (2)
SECURITY INTEREST Recorded Apr 3, 2019
From: PROMEGA CORPORATION; PROMEGA BIOSCIENCES, LLC; TERSO SOLUTIONS, INC.; ORION SEVEN, LLC; PROMEGA AVIATION LLC
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 048790/0259 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 22, 2017
From: WOOD, KEITH V.; LOS, GEORGYI V.; BULLEIT, ROBERT F.; ZIMPRICH, CHAD; KLAUBERT, DIETER; MCDOUGALL, MARK
To: PROMEGA CORPORATION
Reel/Frame 041340/0959 →
Continuity (8)
Continuation 14584834 · Dec 29, 2014
Continuation 13450217 · Apr 18, 2012
Continuation 12975020 · Dec 21, 2010
Division 11786792 · Apr 12, 2007
Division 10768976 · Jan 30, 2004
Provisional Application 60474659 · May 30, 2003
Provisional Application 60444094 · Jan 31, 2003
Related Publication 20170088877A1 · Mar 30, 2017